Dominik Zaugg’s Post

How can we move from #strategy to #impact? How can we develop a #mindset which sees #sustainabilty as driver for #Innovation rather than as #bureaucracy? Please join us this year in #Zürich to discuss it. 13th of June 2024!

How compatible are #profitability and #sustainability and how can companies deal with the interplay between those two factors? How can we move come from strategy to impact and how can we make sustainability the driver for innovation rather than for bureaucracy. 👉 At the 𝗚𝗲𝘀𝗰𝗵ä𝗳𝘁𝘀𝗯𝗲𝗿𝗶𝗰𝗵𝘁𝗲-𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗝𝘂𝗻𝗲 𝟭𝟯, Prof. Dr. Rene Schmidpeter (Berner Fachhochschule BFH) will discuss how #ESG can be effectively integrated as a strategic pillar for creating value in a global company. 📰 Get in the mood for the 15th Geschäftsberichte-Symposium with the article by Prof. Dr. Rene Schmidpeter in the recently published 24th issue of #TheReportingTimes https://lnkd.in/etgjgr3h #gbysymposium24

Saturday thoughts: The Role of ESG in Driving Long-Term Shareholder and Stakeholder Value in Life Sciences. In the life sciences industry, our mission is built on impact: improving lives through innovation, advancing global health, and delivering treatments that truly make a difference. But in today’s evolving landscape, delivering value goes beyond scientific breakthroughs—it requires embedding Environmental, Social, and Governance (ESG) principles at the core of our strategies. Here’s why ESG is critical not just for stakeholders, but also for long-term shareholder value: 🌍 Sustainability Fuels Resilience:Environmental sustainability isn’t just an ethical imperative—it’s a financial one. Reducing carbon footprints, improving energy efficiency, and adopting sustainable practices can mitigate operational risks and lower costs, while preparing businesses for future regulations and market shifts. 🤝 Social Responsibility Builds Trust:Patients, employees, and communities are increasingly looking to life sciences companies to lead with purpose. By improving healthcare access, addressing inequities, and prioritizing patient-centric approaches, we don’t just fulfill our mission—we build trust that translates into stronger, more loyal relationships. 🔍 Governance Drives Accountability:Transparent and ethical governance practices lay the foundation for investor confidence. Clear ESG goals, robust reporting, and alignment with global standards show that a company is not only managing risks effectively but is also poised for sustainable growth. The business case for ESG is clear: companies that prioritize sustainability, equity, and ethical leadership are better positioned to attract top talent, secure long-term investments, and adapt to changing societal expectations. In life sciences, we have a unique opportunity—and responsibility—to create value that extends beyond profits. By aligning shareholder and stakeholder priorities, we can drive innovation, enhance patient outcomes, and ensure a healthier, more sustainable future for all. I’d love to hear how your organization see ESG shaping the future? What steps you have taken? #ESG #LifeSciences #Leadership #Sustainability #ShareholderValue #StakeholderImpact #Impact #Pharma

If your interested in learning and/or sharing; join me later this week at the ESG for Life Sciences Summit. We will be discussing the importance of Health Equity within Healthcare Sustainability. As we all struggle for resources, understanding and socializing the full value of ESG initiatives will be the key to progress in this space.

If you're passionate about empirical research in sustainability, this post is for you. Recently, I had the privilege to author a Medium post summarizing an enlightening seminar by Sabyasachi Saha PhD on 'Empirical Insights into Sustainability' organized by Analytix : IIFT Analytics Club. The session was packed with insightful discussions, covering thought-provoking data on sustainable development, the transition from MDGs to SDGs, advanced HDI measures, and the ongoing efforts to develop impact-oriented qualitative indicators. If this sounds interesting to you, explore more in the detailed Medium post: https://lnkd.in/eH2ZQmdq.

In collaboration with 10th Bridge ESG & created by Emily Blenkley, we are excited to share a white paper titled "Integrating ESG Principles in the Life Sciences Sector: A Pathway to Sustainable Innovation," This insightful paper highlights the critical role of sustainability in the industry and demonstrates how ESG principles can drive innovation and resilience. Whether you are a life sciences professional, investor, or environmental advocate, this white paper provides valuable insights and actionable recommendations for embracing sustainability. At GENerX Life, our mission is to support biotech companies as they grow and deliver groundbreaking drugs to patients. This includes promoting sustainability within the life sciences industry Join the conversation and share your thoughts on this crucial topic. Together, we can shape a more sustainable future for the life sciences sector while advancing groundbreaking therapies for patients worldwide.

❓Does your company incorporate ‘systems thinking’ into their decision making? This report by Ari Ball-Burack, Pablo Salas and Joshua Whyatt, the team behind the Prince of Wales Global Sustainability Fellowship in Radical Innovation and Disruption examines how systems thinking can help businesses and other stakeholders characterise, anticipate, and influence low carbon market disruption. They present a dynamic system drivers (DSD) framework for characterising, anticipating and influencing market disruption. Key findings: ⭐Success in business, finance and governance requires the ability to make sense of the world’s complex, interconnected and ever-changing systems. ⭐The dynamic system drivers (DSD) framework incorporates ‘systems thinking’ into decision-making, helping to characterise, anticipate and influence disruption. ⭐The framework is straightforward to operationalise; as an example, we do so for the power, road transport and agriculture sectors. ⭐Doing so shows that low carbon disruption is already underway or appears inevitable due to both science and economics. However, its nature—including winners, losers, extent, barriers, risks and opportunities—is in some cases uncertain. Read the report to find out how your company could benefit from this framework here 👇 https://lnkd.in/eeZnQ7uh

Here is what you need to know about Vizient’s ESG Impact Spend initiative and how it can enhance healthcare organizations long-term patient outcomes and profitable growth.

Our Future Fit research shows how some businesses are poised to gain a commercial edge by strategically focusing on sustainability or digital transformation. Find out what they're doing differently in the healthcare sector here: https://lnkd.in/eKvaWtaf

Our Future Fit research shows how some businesses are poised to gain a commercial edge by strategically focusing on sustainability or digital transformation. Find out what they're doing differently in the healthcare sector here: https://lnkd.in/eKvaWtaf